It is highly conceivable that p-Tau in the short term leads to long-term upregulation of PP2A, tau can provide feedback and activate the expression of PP2A, and the elevated level of PP2A delays tau phosphorylation and cognitive impairment in the process of natural aging. Here, MAPT is linked to Cognitive impairment.